FORTRESS BIOTECH INC

Fortress Biotech’s share price falls 15% from last month, trading below its 200‑day SMA and 52‑week low, as weak volume and unclear pipeline raise doubts on long‑term growth.

Fortress Biotech’s $1.92 price and 22% slide show a flat, low‑liquidity struggle—no pipeline breakthrough, no partnership, and a 200‑day MA at $2.88. Invest with caution.